Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
IHG says funding challenges holding back new hotel development
-
California Senator Laphonza Butler won't seek new US Senate term next year
-
Form 4 WRAP TECHNOLOGIES, INC. For: Sep 30 Filed by: Bernstein Bruce
-
Form 4 Airbnb, Inc. For: Oct 17 Filed by: Bernstein David C
-
Walt Disney (DIS) sports segment margin is 'lumpy' - Bernstein
-
After disappointing earnings, a prominent tech analyst asks: Is Tesla story broken?
-
Tesla CEO Musk's demand warning sparks selloff in EV stocks
-
Netflix shares surge on big subscriber additions despite Hollywood strikes
-
Bernstein Reiterates Underperform Rating on Tesla (TSLA), asks 'is the story broken?'
-
Fears that China boost for L'Oreal's beauty label sales may not last
-
Water Street Healthcare Partners Appoints Boris Bernstein as Managing Director of Europe
-
United Airlines shares drop 5% as guidance falls short of analyst estimates
-
Nvidia details advanced AI chips blocked by new export controls
-
Bernstein’s top 15 stocks for the next 6 months
-
Bernstein struggles to see what could drive JD.com (JD) turnaround
-
Form 144 Airbnb, Inc. Filed by: Bernstein David C
-
Chevron (CVX) vs Exxon (XOM): Which oil major stock is better? This analyst has the answer
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Origin Materials, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds CS Disco, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Integra LifeSciences Holding Corporation Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Archer Aviation, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds DLocal Limited Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Tandem Diabetes Care, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Leslie’s, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Masimo Corporation Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Hawaiian Electric Industries, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds NAPCO Security Technologies, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds AeroVironment, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds UiPath, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds PacWest Bancorp Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Enviva, Inc. Investors of Upcoming Deadline
-
DEADLINE ALERT: Bernstein Liebhard LLP Reminds DigitalOcean Holdings, Inc. Investors of Upcoming Deadline
-
SEC Obtains Emergency Relief To Halt Nearly $130 Million Fraud Targeting Indian American Community
-
Snap shares jump as leaked 2024 user target exceed Wall St expectations
-
Bernstein upgrades Porsche to Market-Perform as automaker changes strategy
-
Twin engines power this stock's 10% FCF yield - Bernstein
-
Bernstein Downgrades JD.com, Inc (JD) to Market Perform, 'struggle to think the company can outgrow the likes of PDD and Douyin'
-
Netflix may hike prices after success of password-sharing crackdown
-
Grieving and on edge, US Jews, Muslims seek solace as Hamas-Israel war rages
-
Is Tesla (TSLA) a car or tech company?
-
Maze Therapeutics to Present New Data for APOL1 Kidney Disease in Proprietary Chronic Preclinical Model Demonstrating Reversal of Albuminuria
-
Vkind Names 4 Nonprofit Partners for Its Upcoming Vkind Experience
-
Leading Lawyers From Around the World Publish Statement Condemning Terrorism in Israel
-
Bernstein struggles to justify Clorox (CLX) downside from here
-
AB to Report Third Quarter 2023 Results on October 26, 2023
-
Here's why this controversial brand could boost one sportswear giant in 2024 - Bernstein
-
TelevisaUnivision to Report Third Quarter 2023 Results on Wednesday, October 25
-
Birkenstock (BIRK) IPO Opens Below Offering Price
-
Maze Therapeutics Announces Publication of Research Demonstrating Newly Identified Variant for APOL1 Kidney Disease is Associated with Reduced Risk of APOL1 Kidney Disease
-
Successful Silicon Pour and Validation of All Critical Milestones in HPQ PUREVAP™ Gen3 QRR Testing

